المؤلفون: Paz-Ares, Luis G., Ciuleanu, Tudor-Eliade, Lee, Jong-seok, Urban, Laszlo, Bernabe Caro, Reyes, Park, Keunchil, Sakai, Hiroshi, Ohe, Yuichiro, Nishio, Makoto, Pluzanski, Adam, Ramalingam, Suresh S., Brahmer, Julie R., Borghaei, Hossein, O'Byrne, Kenneth John, Hellmann, Matthew D., Memaj, Arteid, Bushong, Judith, Tran, Phuong, Reck, Martin

المصدر: Journal of Clinical Oncology

العلاقة: Paz-Ares, Luis G., Ciuleanu, Tudor-Eliade, Lee, Jong-seok, Urban, Laszlo, Bernabe Caro, Reyes, Park, Keunchil, Sakai, Hiroshi, Ohe, Yuichiro, Nishio, Makoto, Pluzanski, Adam, Ramalingam, Suresh S., Brahmer, Julie R., Borghaei, Hossein, O'Byrne, Kenneth John, Hellmann, Matthew D., Memaj, Arteid, Bushong, Judith, Tran, Phuong, & Reck, Martin (2021) Nivolumab (NIVO) plus ipilimumab (IPI) versus chemotherapy (chemo) as first-line (1L) treatment for advanced non-small cell lung cancer (NSCLC): 4-year update from CheckMate 227. Journal of Clinical Oncology, 39(15_suppl), p. 9016.; https://eprints.qut.edu.au/233100Test/

الإتاحة: https://doi.org/10.1200/JCO.2021.39.15_suppl.9016Test
https://eprints.qut.edu.au/233100Test/

المؤلفون: Ramalingam, Suresh S., Ciuleanu, Tudor Eliade, Pluzanski, Adam, Lee, Jong-seok, Schenker, Michael, Bernabe Caro, Reyes, Lee, Ki Hyeong, Zurawski, Bogdan, Audigier-valette, Clarisse, Provencio, Mariano, Linardou, Helena, Kim, Sang-we, Borghaei, Hossein, Hellmann, Matthew David, O'byrne, Kenneth John, Paz-ares, Luis G., Reck, Martin, Nathan, Faith Ellen, Brahmer, Julie R.

المصدر: Journal of Clinical Oncology

العلاقة: Ramalingam, Suresh S., Ciuleanu, Tudor Eliade, Pluzanski, Adam, Lee, Jong-seok, Schenker, Michael, Bernabe Caro, Reyes, Lee, Ki Hyeong, Zurawski, Bogdan, Audigier-valette, Clarisse, Provencio, Mariano, Linardou, Helena, Kim, Sang-we, Borghaei, Hossein, Hellmann, Matthew David, O'byrne, Kenneth John, Paz-ares, Luis G., Reck, Martin, Nathan, Faith Ellen, & Brahmer, Julie R. (2020) Nivolumab + ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 Part 1. Journal of Clinical Oncology, 38(15_suppl), p. 9500.; https://eprints.qut.edu.au/233108Test/

الإتاحة: https://doi.org/10.1200/JCO.2020.38.15_suppl.9500Test
https://eprints.qut.edu.au/233108Test/

المؤلفون: Reck, Martin, Remon, Jordi, Hellmann, Matthew D

المصدر: Journal of Clinical Oncology; 2/20/2022, Vol. 40 Issue 6, p586-597, 12p

المؤلفون: Ready, Neal, Hellmann, Matthew D., Awad, Mark M., Otterson, Gregory A., Gutierrez, Martin, Gainor, Justin F., Borghaei, Hossein, Jolivet, Jacques, Horn, Leora, Mates, Mihaela, Brahmer, Julie, Rabinowitz, Ian, Reddy, Pavan S., Chesney, Jason, Orcutt, James, Spigel, David R., Reck, Martin, O'Byrne, Kenneth John, Paz-Ares, Luis, Hu, Wenhua, Phd, Zerba, Kim, Li, Xuemei, Lestini, Brian, Geese, William J., Szustakowski, Joseph D., Green, George, Chang, Han, Ramalingam, Suresh S.

المصدر: Journal of Clinical Oncology

العلاقة: Ready, Neal, Hellmann, Matthew D., Awad, Mark M., Otterson, Gregory A., Gutierrez, Martin, Gainor, Justin F., Borghaei, Hossein, Jolivet, Jacques, Horn, Leora, Mates, Mihaela, Brahmer, Julie, Rabinowitz, Ian, Reddy, Pavan S., Chesney, Jason, Orcutt, James, Spigel, David R., Reck, Martin, O'Byrne, Kenneth John, Paz-Ares, Luis, Hu, Wenhua, Phd, Zerba, Kim, Li, Xuemei, Lestini, Brian, Geese, William J., Szustakowski, Joseph D., Green, George, Chang, Han, & Ramalingam, Suresh S. (2019) First-line nivolumab plus ipilimumab in advanced non-small-cell lung cancer (CheckMate 568): Outcomes by programmed death ligand 1 and tumor mutational burden as biomarkers. Journal of Clinical Oncology, 37(12), pp. 992-1000.; https://eprints.qut.edu.au/227565Test/

الإتاحة: https://doi.org/10.1200/JCO.18.01042Test
https://eprints.qut.edu.au/227565Test/

المؤلفون: Reck, Martin, Hellmann, Matthew David, Paz-ares, Luis G., Ramalingam, Suresh S., Brahmer, Julie R., O'Byrne, Kenneth John, Bhagavatheeswaran, Prabhu, Nathan, Faith Ellen, Borghaei, Hossein

المصدر: Journal of Clinical Oncology

العلاقة: Reck, Martin, Hellmann, Matthew David, Paz-ares, Luis G., Ramalingam, Suresh S., Brahmer, Julie R., O'Byrne, Kenneth John, Bhagavatheeswaran, Prabhu, Nathan, Faith Ellen, & Borghaei, Hossein (2018) Nivolumab (Nivo) + Ipilimumab (Ipi) vs Platinum-Doublet Chemotherapy (Chemo) as First-line (1L) Treatment (Tx) for Advanced Non-Small Cell Lung Cancer (NSCLC): Safety Analysis and Patient-Reported Outcomes (PROs) From CheckMate 227. Journal of Clinical Oncology, 36(15_suppl), p. 9020.; https://eprints.qut.edu.au/233162Test/

الإتاحة: https://doi.org/10.1200/JCO.2018.36.15_suppl.9020Test
https://eprints.qut.edu.au/233162Test/

المؤلفون: Borghaei, Hossein, Hellmann, Matthew David, Paz-ares, Luis G., Ramalingam, Suresh S., Reck, Martin, O'Byrne, Kenneth John, Bhagavatheeswaran, Prabhu, Nathan, Faith Ellen, Brahmer, Julie R.

المصدر: Journal of Clinical Oncology

العلاقة: Borghaei, Hossein, Hellmann, Matthew David, Paz-ares, Luis G., Ramalingam, Suresh S., Reck, Martin, O'Byrne, Kenneth John, Bhagavatheeswaran, Prabhu, Nathan, Faith Ellen, & Brahmer, Julie R. (2018) Nivolumab (Nivo) + platinum-doublet chemotherapy (Chemo) vs chemo as first-line (1L) treatment (Tx) for advanced non-small cell lung cancer (NSCLC) with. Journal of Clinical Oncology, 36(15_suppl), p. 9001.; https://eprints.qut.edu.au/233157Test/

الإتاحة: https://doi.org/10.1200/JCO.2018.36.15_suppl.9001Test
https://eprints.qut.edu.au/233157Test/

المؤلفون: Osorio, Juan C., Arbour, Kathryn C., Le, Dung T., Durham, Jennifer N., Plodkowski, Andrew J., Halpenny, Darragh F., Ginsberg, Michelle S., Sawan, Peter, Crompton, Joseph G., Yu, Helena A., Namakydoust, Azadeh, Nabet, Barzin Y., Chaft, Jamie E., Riely, Gregory J., Rizvi, Hira, Diaz, Luis A., Hellmann, Matthew D.

المصدر: Journal of Clinical Oncology; 12/20/2019, Vol. 37 Issue 36, p3546-3555, 11p

المؤلفون: Phillips, Gregory S., Wu, Jennifer, Hellmann, Matthew D., Postow, Michael A., Rizvi, Naiyer A., Freites-Martinez, Azael, Chan, Donald, Dusza, Stephen, Motzer, Robert J., Rosenberg, Jonathan E., Callahan, Margaret K., Chapman, Paul B., Geskin, Larisa, Lopez, Adriana T., Reed, Vanessa A., Fabbrocini, Gabriella, Annunziata, Maria Carmela, Kukoyi, Oluwaseun, Pabani, Aliyah, Yang, Chih-Hsun

المصدر: Journal of Clinical Oncology; 10/20/2019, Vol. 37 Issue 30, p2746-2758, 14p

المؤلفون: Garon, Edward B., Hellmann, Matthew D., Rizvi, Naiyer A., Carcereny, Enric, Leighl, Natasha B., Ahn, Myung-Ju, Eder, Joseph Paul, Balmanoukian, Ani S., Aggarwal, Charu, Horn, Leora, Patnaik, Amita, Gubens, Matthew, Ramalingam, Suresh S., Felip, Enriqueta, Goldman, Jonathan W., Scalzo, Cathie, Jensen, Erin, Kush, Debra A., Hui, Rina

المصدر: Journal of Clinical Oncology; 10/1/2019, Vol. 37 Issue 28, p2518-2527, 11p

المؤلفون: Offin, Michael, Guo, Robin, Wu, Stephanie L., Sabari, Joshua, Land, Josiah D., Ni, Ai, Montecalvo, Joseph, Halpenny, Darragh F., Buie, Larry W., Pak, Terry, Liu, Dazhi, Benayed, Ryma, Arcila, Maria, Ladanyi, Marc, Rekhtman, Natasha, Riely, Gregory J., Hellmann, Matthew D., Kris, Mark G., Rudin, Charles M., Li, Bob T.

المصدر: JCO Precision Oncology; 5/16/2019, Vol. 3, p1-8, 8p

مصطلحات موضوعية: LUNG cancer, IMMUNOTHERAPY, NON-small-cell lung carcinoma